Efficacy and Safety of Lumateperone compared to Quetiapine in Indian patients with Bipolar II depression: A subgroup analysis based on age Article Swipe
A. Dharmadhikari
,
P. K. Chaurasia
,
Yash Patel
,
Devendra Kumar Choudhary
,
P. L. Dasud
,
M. Bhirud
,
P. S. Meena
,
Farid Ullah Shah
,
G. Ganesan
,
B. P. S. Rathour
,
Kamila B. Mistry
,
Moumita Dutta
,
A. Ramaraju
,
Sameer Belvi Mangalwedhe
,
Suresh Goyal
,
Gauri Kulkarni
,
Amal K. Mukhopadhyay
,
Poonam Chaudhary
,
G. T. Harsha
,
Mangla Parikh
,
Sumi Dey
,
Sumanta Sarkhel
,
N.V.V. Jyothi
,
Aditya Kumar
,
N. K. Sooch
,
S K Saha
,
P. H. Devkare
,
Anil N. Shetty
,
Dipak D. Patil
,
P. Ghadge
,
Anupama Mane
,
Suyog Mehta
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1192/j.eurpsy.2025.1086
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1192/j.eurpsy.2025.1086
Introduction Lumateperone, an atypical antipsychotic drug, has a dual mechanism of action by combination of activity at central serotonin (5-HT2A) and dopamine (D2) receptors. Objectives This subgroup analysis of an Indian Phase 3 study was conducted to evaluate the efficacy and safety of Lumateperone 42mg compared to Quetiapine 300mg in treatment of Bipolar II depression when stratified based on age (18-45, >45-65). Methods The phase-III, randomized, multi-centric, assessor-blind, parallel-group, active-controlled, comparative, non-inferiority study included Indian patients with Bipolar II depression with moderate severity having a Montgomery-Asberg depression rating scale (MADRS) score ≥20 and Clinical global impression–bipolar version–severity (CGI-BP-S) score ≥4. The study was conducted after receiving regulatory and ethics committee approvals. The patients were randomized (1:1) to either receive Lumateperone 42mg [Test] or Quetiapine 300mg [Comparator] for 6 weeks. The patients were stratified based on age: Subgroup 1 [S1]: 18-45 years and Subgroup 2 [S2]: >45-65 years. For efficacy outcomes MADRS score, CGI-BP-S (total score, depression subscore and overall bipolar illness subscore), and Quality of life enjoyment and satisfaction-short form questionnaire (Q-LES-Q-SF) score were evaluated and for safety outcomes treatment emergent adverse events (TEAEs) were assessed. [Clinical trial registration: CTRI/2023/10/058583] Results This subgroup analysis included 462 patients, out of which 320 in S1[Test=159; Comparator=161] and 142 in S2[Test=72; Comparator=70]. The baseline demographic characteristics were comparable in between treatment arms across subgroups. The primary endpoint of reduction in MADRS score from baseline to Day 42 in Test arm was non-inferior to Comparator arm in both subgroups [Figure 1] as the upper 95% CI was below the pre-defined margin of 3.0. The reduction of CGI-BP-S (total score, depression subscore and overall bipolar illness subscore) from Day 14 to Day 42 were comparable in both Test and Comparator arms in both subgroups. The improvement in Q-LES-Q-SF score from baseline to Day 42 were comparable in both Test and Comparator arms in both subgroups. The incidence of TEAEs were comparable in both treatment arms [S1: Test=31.4% and Comparator=36.6%; S2: Test=41.7% and Comparator=32.9%] and no serious adverse events were reported. Image 1: Conclusions This subgroup analysis demonstrated that Lumateperone 42mg is non-inferior to Quetiapine 300mg in treatment of Bipolar II depression as assessed via MADRS score from baseline to Day 42, irrespective of age of the patients and both treatments were found to be well tolerated. Hence, Lumateperone can be considered as valuable treatment option in management of Bipolar II depression. Disclosure of Interest A. Dharmadhikari: None Declared, P. Chaurasia: None Declared, Y. Patel: None Declared, D. Choudhary: None Declared, P. Dasud: None Declared, M. Bhirud: None Declared, P. Meena: None Declared, F. Shah: None Declared, G. Ganesan: None Declared, B. P. Rathour: None Declared, K. Mistry: None Declared, M. Dutta: None Declared, A. Ramaraju: None Declared, S. Mangalwedhe: None Declared, S. G. Goyal: None Declared, G. Kulkarni: None Declared, A. Mukhopadhyay: None Declared, P. Chaudhary: None Declared, G. T. Harsha: None Declared, M. Parikh: None Declared, S. Dey: None Declared, S. Sarkhel: None Declared, N. Jyothi: None Declared, A. Kumar: None Declared, N. Sooch: None Declared, A. Shetty Employee of: Sun Pharma, S. Saha Employee of: Sun Pharma, P. Devkare Employee of: Sun Pharma, A. Shetty Employee of: Sun Pharma, D. Patil Employee of: Sun Pharma, P. Ghadge Employee of: Sun Pharma, A. Mane Employee of: Sun Pharma, S. Mehta Employee of: Sun Pharma
Related Topics
Concepts
No concepts available.
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1192/j.eurpsy.2025.1086
- https://www.cambridge.org/core/services/aop-cambridge-core/content/view/EE6488C9326FA55603972FE2BF7B69B0/S0924933825010867a.pdf/div-class-title-efficacy-and-safety-of-lumateperone-compared-to-quetiapine-in-indian-patients-with-bipolar-ii-depression-a-subgroup-analysis-based-on-age-div.pdf
- OA Status
- gold
- OpenAlex ID
- https://openalex.org/W4414179871
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4414179871Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1192/j.eurpsy.2025.1086Digital Object Identifier
- Title
-
Efficacy and Safety of Lumateperone compared to Quetiapine in Indian patients with Bipolar II depression: A subgroup analysis based on ageWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-04-01Full publication date if available
- Authors
-
A. Dharmadhikari, P. K. Chaurasia, Yash Patel, Devendra Kumar Choudhary, P. L. Dasud, M. Bhirud, P. S. Meena, Farid Ullah Shah, G. Ganesan, B. P. S. Rathour, Kamila B. Mistry, Moumita Dutta, A. Ramaraju, Sameer Belvi Mangalwedhe, Suresh Goyal, Gauri Kulkarni, Amal K. Mukhopadhyay, Poonam Chaudhary, G. T. Harsha, Mangla Parikh, Sumi Dey, Sumanta Sarkhel, N.V.V. Jyothi, Aditya Kumar, N. K. Sooch, S K Saha, P. H. Devkare, Anil N. Shetty, Dipak D. Patil, P. Ghadge, Anupama Mane, Suyog MehtaList of authors in order
- Landing page
-
https://doi.org/10.1192/j.eurpsy.2025.1086Publisher landing page
- PDF URL
-
https://www.cambridge.org/core/services/aop-cambridge-core/content/view/EE6488C9326FA55603972FE2BF7B69B0/S0924933825010867a.pdf/div-class-title-efficacy-and-safety-of-lumateperone-compared-to-quetiapine-in-indian-patients-with-bipolar-ii-depression-a-subgroup-analysis-based-on-age-div.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.cambridge.org/core/services/aop-cambridge-core/content/view/EE6488C9326FA55603972FE2BF7B69B0/S0924933825010867a.pdf/div-class-title-efficacy-and-safety-of-lumateperone-compared-to-quetiapine-in-indian-patients-with-bipolar-ii-depression-a-subgroup-analysis-based-on-age-div.pdfDirect OA link when available
- Cited by
-
0Total citation count in OpenAlex
Full payload
| id | https://openalex.org/W4414179871 |
|---|---|
| doi | https://doi.org/10.1192/j.eurpsy.2025.1086 |
| ids.doi | https://doi.org/10.1192/j.eurpsy.2025.1086 |
| ids.openalex | https://openalex.org/W4414179871 |
| fwci | 0.0 |
| type | article |
| title | Efficacy and Safety of Lumateperone compared to Quetiapine in Indian patients with Bipolar II depression: A subgroup analysis based on age |
| biblio.issue | S1 |
| biblio.volume | 68 |
| biblio.last_page | S527 |
| biblio.first_page | S526 |
| topics[0].id | https://openalex.org/T10854 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9927999973297119 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2738 |
| topics[0].subfield.display_name | Psychiatry and Mental health |
| topics[0].display_name | Bipolar Disorder and Treatment |
| topics[1].id | https://openalex.org/T13283 |
| topics[1].field.id | https://openalex.org/fields/32 |
| topics[1].field.display_name | Psychology |
| topics[1].score | 0.9186999797821045 |
| topics[1].domain.id | https://openalex.org/domains/2 |
| topics[1].domain.display_name | Social Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/3205 |
| topics[1].subfield.display_name | Experimental and Cognitive Psychology |
| topics[1].display_name | Mental Health Research Topics |
| topics[2].id | https://openalex.org/T10023 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9172000288963318 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2738 |
| topics[2].subfield.display_name | Psychiatry and Mental health |
| topics[2].display_name | Schizophrenia research and treatment |
| is_xpac | False |
| apc_list.value | 2200 |
| apc_list.currency | EUR |
| apc_list.value_usd | 2372 |
| apc_paid.value | 2200 |
| apc_paid.currency | EUR |
| apc_paid.value_usd | 2372 |
| language | en |
| locations[0].id | doi:10.1192/j.eurpsy.2025.1086 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S87202501 |
| locations[0].source.issn | 0924-9338, 1778-3585 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 0924-9338 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | European Psychiatry |
| locations[0].source.host_organization | https://openalex.org/P4310311721 |
| locations[0].source.host_organization_name | Cambridge University Press |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310311721, https://openalex.org/P4310311702 |
| locations[0].source.host_organization_lineage_names | Cambridge University Press, University of Cambridge |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.cambridge.org/core/services/aop-cambridge-core/content/view/EE6488C9326FA55603972FE2BF7B69B0/S0924933825010867a.pdf/div-class-title-efficacy-and-safety-of-lumateperone-compared-to-quetiapine-in-indian-patients-with-bipolar-ii-depression-a-subgroup-analysis-based-on-age-div.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | European Psychiatry |
| locations[0].landing_page_url | https://doi.org/10.1192/j.eurpsy.2025.1086 |
| locations[1].id | pmh:oai:europepmc.org:11246914 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S4306400806 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | Europe PMC (PubMed Central) |
| locations[1].source.host_organization | https://openalex.org/I1303153112 |
| locations[1].source.host_organization_name | European Bioinformatics Institute |
| locations[1].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[1].license | other-oa |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | https://openalex.org/licenses/other-oa |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | |
| locations[1].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12436946 |
| indexed_in | crossref, doaj |
| authorships[0].author.id | https://openalex.org/A5112140325 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | A. Dharmadhikari |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | A. Dharmadhikari |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5080415634 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-4125-6144 |
| authorships[1].author.display_name | P. K. Chaurasia |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | P. K. Chaurasia |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5018160147 |
| authorships[2].author.orcid | https://orcid.org/0009-0002-9807-4819 |
| authorships[2].author.display_name | Yash Patel |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Y. Patel |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5045341365 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-2390-1437 |
| authorships[3].author.display_name | Devendra Kumar Choudhary |
| authorships[3].countries | IN |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I2802359691 |
| authorships[3].affiliations[0].raw_affiliation_string | GSVM Medical College |
| authorships[3].institutions[0].id | https://openalex.org/I2802359691 |
| authorships[3].institutions[0].ror | https://ror.org/002ztb251 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I2802359691 |
| authorships[3].institutions[0].country_code | IN |
| authorships[3].institutions[0].display_name | Ganesh Shankar Vidyarthi Memorial Medical College |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | D. Choudhary |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | GSVM Medical College |
| authorships[4].author.id | https://openalex.org/A5119613057 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | P. L. Dasud |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | P. L. Dasud |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5084976444 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | M. Bhirud |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | M. Bhirud |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5036113398 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-0947-5646 |
| authorships[6].author.display_name | P. S. Meena |
| authorships[6].countries | IN |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210104297 |
| authorships[6].affiliations[0].raw_affiliation_string | Jawahar Lal Nehru Medical College |
| authorships[6].institutions[0].id | https://openalex.org/I4210104297 |
| authorships[6].institutions[0].ror | https://ror.org/01a4d6k20 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210104297, https://openalex.org/I4210125823 |
| authorships[6].institutions[0].country_code | IN |
| authorships[6].institutions[0].display_name | Jawaharlal Nehru Medical College |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | P. S. Meena |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Jawahar Lal Nehru Medical College |
| authorships[7].author.id | https://openalex.org/A5056420964 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-6824-9350 |
| authorships[7].author.display_name | Farid Ullah Shah |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | F. Shah |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5029206839 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | G. Ganesan |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | G. Ganesan |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5119623521 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | B. P. S. Rathour |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | B. P. S. Rathour |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5045182649 |
| authorships[10].author.orcid | https://orcid.org/0009-0006-7637-6604 |
| authorships[10].author.display_name | Kamila B. Mistry |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | K. Mistry |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5033030403 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-8959-9579 |
| authorships[11].author.display_name | Moumita Dutta |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | M. Dutta |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5117107192 |
| authorships[12].author.orcid | |
| authorships[12].author.display_name | A. Ramaraju |
| authorships[12].affiliations[0].raw_affiliation_string | Harshamitra Super Speciality Cancer Center and research institute |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | A. Ramaraju |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Harshamitra Super Speciality Cancer Center and research institute |
| authorships[13].author.id | https://openalex.org/A5110843893 |
| authorships[13].author.orcid | |
| authorships[13].author.display_name | Sameer Belvi Mangalwedhe |
| authorships[13].countries | IN |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I77799889 |
| authorships[13].affiliations[0].raw_affiliation_string | Karnataka Institute of Medical Sciences |
| authorships[13].institutions[0].id | https://openalex.org/I77799889 |
| authorships[13].institutions[0].ror | https://ror.org/03d6dzy78 |
| authorships[13].institutions[0].type | healthcare |
| authorships[13].institutions[0].lineage | https://openalex.org/I77799889 |
| authorships[13].institutions[0].country_code | IN |
| authorships[13].institutions[0].display_name | Karnataka Institute of Medical Sciences |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | S. B. Mangalwedhe |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Karnataka Institute of Medical Sciences |
| authorships[14].author.id | https://openalex.org/A5102307268 |
| authorships[14].author.orcid | |
| authorships[14].author.display_name | Suresh Goyal |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | S. G. Goyal |
| authorships[14].is_corresponding | False |
| authorships[15].author.id | https://openalex.org/A5045025289 |
| authorships[15].author.orcid | https://orcid.org/0000-0002-1694-9451 |
| authorships[15].author.display_name | Gauri Kulkarni |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | G. Kulkarni |
| authorships[15].is_corresponding | False |
| authorships[16].author.id | https://openalex.org/A5109040610 |
| authorships[16].author.orcid | |
| authorships[16].author.display_name | Amal K. Mukhopadhyay |
| authorships[16].countries | IN |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I158908536 |
| authorships[16].affiliations[0].raw_affiliation_string | Nil Ratan Sircar Medical College and Hospital |
| authorships[16].institutions[0].id | https://openalex.org/I158908536 |
| authorships[16].institutions[0].ror | https://ror.org/04zpy9a42 |
| authorships[16].institutions[0].type | education |
| authorships[16].institutions[0].lineage | https://openalex.org/I158908536, https://openalex.org/I226431899 |
| authorships[16].institutions[0].country_code | IN |
| authorships[16].institutions[0].display_name | Nil Ratan Sircar Medical College and Hospital |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | A. Mukhopadhyay |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Nil Ratan Sircar Medical College and Hospital |
| authorships[17].author.id | https://openalex.org/A5063005990 |
| authorships[17].author.orcid | https://orcid.org/0000-0001-5529-5561 |
| authorships[17].author.display_name | Poonam Chaudhary |
| authorships[17].affiliations[0].raw_affiliation_string | GMERS Medical College |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | P. Chaudhary |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | GMERS Medical College |
| authorships[18].author.id | https://openalex.org/A5072450340 |
| authorships[18].author.orcid | |
| authorships[18].author.display_name | G. T. Harsha |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | G. T. Harsha |
| authorships[18].is_corresponding | False |
| authorships[19].author.id | https://openalex.org/A5035975695 |
| authorships[19].author.orcid | |
| authorships[19].author.display_name | Mangla Parikh |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | M. Parikh |
| authorships[19].is_corresponding | False |
| authorships[20].author.id | https://openalex.org/A5068806294 |
| authorships[20].author.orcid | https://orcid.org/0000-0002-1553-6372 |
| authorships[20].author.display_name | Sumi Dey |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | S. Dey |
| authorships[20].is_corresponding | False |
| authorships[21].author.id | https://openalex.org/A5015573296 |
| authorships[21].author.orcid | https://orcid.org/0000-0001-5980-2612 |
| authorships[21].author.display_name | Sumanta Sarkhel |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | S. Sarkhel |
| authorships[21].is_corresponding | False |
| authorships[22].author.id | https://openalex.org/A5078332118 |
| authorships[22].author.orcid | https://orcid.org/0000-0002-4959-989X |
| authorships[22].author.display_name | N.V.V. Jyothi |
| authorships[22].author_position | middle |
| authorships[22].raw_author_name | N. U. Jyothi |
| authorships[22].is_corresponding | False |
| authorships[23].author.id | https://openalex.org/A5101810073 |
| authorships[23].author.orcid | https://orcid.org/0009-0003-1544-8844 |
| authorships[23].author.display_name | Aditya Kumar |
| authorships[23].countries | IN |
| authorships[23].affiliations[0].institution_ids | https://openalex.org/I2799711398 |
| authorships[23].affiliations[0].raw_affiliation_string | S N Medical College |
| authorships[23].institutions[0].id | https://openalex.org/I2799711398 |
| authorships[23].institutions[0].ror | https://ror.org/02d57ed54 |
| authorships[23].institutions[0].type | healthcare |
| authorships[23].institutions[0].lineage | https://openalex.org/I2799711398 |
| authorships[23].institutions[0].country_code | IN |
| authorships[23].institutions[0].display_name | Sarojini Naidu Medical College |
| authorships[23].author_position | middle |
| authorships[23].raw_author_name | A. Kumar |
| authorships[23].is_corresponding | False |
| authorships[23].raw_affiliation_strings | S N Medical College |
| authorships[24].author.id | https://openalex.org/A5086691283 |
| authorships[24].author.orcid | |
| authorships[24].author.display_name | N. K. Sooch |
| authorships[24].countries | IN |
| authorships[24].affiliations[0].institution_ids | https://openalex.org/I4210088867 |
| authorships[24].affiliations[0].raw_affiliation_string | Dayanand Medical College & Hospital |
| authorships[24].institutions[0].id | https://openalex.org/I4210088867 |
| authorships[24].institutions[0].ror | https://ror.org/005fgpm31 |
| authorships[24].institutions[0].type | education |
| authorships[24].institutions[0].lineage | https://openalex.org/I4210088867 |
| authorships[24].institutions[0].country_code | IN |
| authorships[24].institutions[0].display_name | Dayanand Medical College & Hospital |
| authorships[24].author_position | middle |
| authorships[24].raw_author_name | N. K. Sooch |
| authorships[24].is_corresponding | False |
| authorships[24].raw_affiliation_strings | Dayanand Medical College & Hospital |
| authorships[25].author.id | https://openalex.org/A5109029706 |
| authorships[25].author.orcid | |
| authorships[25].author.display_name | S K Saha |
| authorships[25].countries | JP |
| authorships[25].affiliations[0].institution_ids | https://openalex.org/I4210144945 |
| authorships[25].affiliations[0].raw_affiliation_string | Sun Pharma |
| authorships[25].institutions[0].id | https://openalex.org/I4210144945 |
| authorships[25].institutions[0].ror | https://ror.org/04vnqkx80 |
| authorships[25].institutions[0].type | company |
| authorships[25].institutions[0].lineage | https://openalex.org/I4210144945 |
| authorships[25].institutions[0].country_code | JP |
| authorships[25].institutions[0].display_name | Sun Pharma (Japan) |
| authorships[25].author_position | middle |
| authorships[25].raw_author_name | S. Saha |
| authorships[25].is_corresponding | False |
| authorships[25].raw_affiliation_strings | Sun Pharma |
| authorships[26].author.id | https://openalex.org/A5087475910 |
| authorships[26].author.orcid | |
| authorships[26].author.display_name | P. H. Devkare |
| authorships[26].countries | JP |
| authorships[26].affiliations[0].institution_ids | https://openalex.org/I4210144945 |
| authorships[26].affiliations[0].raw_affiliation_string | Sun Pharma |
| authorships[26].institutions[0].id | https://openalex.org/I4210144945 |
| authorships[26].institutions[0].ror | https://ror.org/04vnqkx80 |
| authorships[26].institutions[0].type | company |
| authorships[26].institutions[0].lineage | https://openalex.org/I4210144945 |
| authorships[26].institutions[0].country_code | JP |
| authorships[26].institutions[0].display_name | Sun Pharma (Japan) |
| authorships[26].author_position | middle |
| authorships[26].raw_author_name | P. H. Devkare |
| authorships[26].is_corresponding | False |
| authorships[26].raw_affiliation_strings | Sun Pharma |
| authorships[27].author.id | https://openalex.org/A5102718074 |
| authorships[27].author.orcid | https://orcid.org/0000-0002-0197-7441 |
| authorships[27].author.display_name | Anil N. Shetty |
| authorships[27].countries | JP |
| authorships[27].affiliations[0].institution_ids | https://openalex.org/I4210144945 |
| authorships[27].affiliations[0].raw_affiliation_string | Sun Pharma |
| authorships[27].institutions[0].id | https://openalex.org/I4210144945 |
| authorships[27].institutions[0].ror | https://ror.org/04vnqkx80 |
| authorships[27].institutions[0].type | company |
| authorships[27].institutions[0].lineage | https://openalex.org/I4210144945 |
| authorships[27].institutions[0].country_code | JP |
| authorships[27].institutions[0].display_name | Sun Pharma (Japan) |
| authorships[27].author_position | middle |
| authorships[27].raw_author_name | A. Shetty |
| authorships[27].is_corresponding | False |
| authorships[27].raw_affiliation_strings | Sun Pharma |
| authorships[28].author.id | https://openalex.org/A5013037600 |
| authorships[28].author.orcid | https://orcid.org/0000-0002-4826-4537 |
| authorships[28].author.display_name | Dipak D. Patil |
| authorships[28].countries | JP |
| authorships[28].affiliations[0].institution_ids | https://openalex.org/I4210144945 |
| authorships[28].affiliations[0].raw_affiliation_string | Sun Pharma |
| authorships[28].institutions[0].id | https://openalex.org/I4210144945 |
| authorships[28].institutions[0].ror | https://ror.org/04vnqkx80 |
| authorships[28].institutions[0].type | company |
| authorships[28].institutions[0].lineage | https://openalex.org/I4210144945 |
| authorships[28].institutions[0].country_code | JP |
| authorships[28].institutions[0].display_name | Sun Pharma (Japan) |
| authorships[28].author_position | middle |
| authorships[28].raw_author_name | D. Patil |
| authorships[28].is_corresponding | False |
| authorships[28].raw_affiliation_strings | Sun Pharma |
| authorships[29].author.id | https://openalex.org/A5110961756 |
| authorships[29].author.orcid | |
| authorships[29].author.display_name | P. Ghadge |
| authorships[29].countries | JP |
| authorships[29].affiliations[0].institution_ids | https://openalex.org/I4210144945 |
| authorships[29].affiliations[0].raw_affiliation_string | Sun Pharma |
| authorships[29].institutions[0].id | https://openalex.org/I4210144945 |
| authorships[29].institutions[0].ror | https://ror.org/04vnqkx80 |
| authorships[29].institutions[0].type | company |
| authorships[29].institutions[0].lineage | https://openalex.org/I4210144945 |
| authorships[29].institutions[0].country_code | JP |
| authorships[29].institutions[0].display_name | Sun Pharma (Japan) |
| authorships[29].author_position | middle |
| authorships[29].raw_author_name | P. Ghadge |
| authorships[29].is_corresponding | False |
| authorships[29].raw_affiliation_strings | Sun Pharma |
| authorships[30].author.id | https://openalex.org/A5076406821 |
| authorships[30].author.orcid | https://orcid.org/0000-0002-0841-8984 |
| authorships[30].author.display_name | Anupama Mane |
| authorships[30].countries | JP |
| authorships[30].affiliations[0].institution_ids | https://openalex.org/I4210144945 |
| authorships[30].affiliations[0].raw_affiliation_string | Sun Pharma |
| authorships[30].institutions[0].id | https://openalex.org/I4210144945 |
| authorships[30].institutions[0].ror | https://ror.org/04vnqkx80 |
| authorships[30].institutions[0].type | company |
| authorships[30].institutions[0].lineage | https://openalex.org/I4210144945 |
| authorships[30].institutions[0].country_code | JP |
| authorships[30].institutions[0].display_name | Sun Pharma (Japan) |
| authorships[30].author_position | last |
| authorships[30].raw_author_name | A. Mane |
| authorships[30].is_corresponding | False |
| authorships[30].raw_affiliation_strings | Sun Pharma |
| authorships[31].author.id | https://openalex.org/A5037908769 |
| authorships[31].author.orcid | https://orcid.org/0000-0001-7553-4128 |
| authorships[31].author.display_name | Suyog Mehta |
| authorships[31].countries | JP |
| authorships[31].affiliations[0].institution_ids | https://openalex.org/I4210144945 |
| authorships[31].affiliations[0].raw_affiliation_string | Sun Pharma |
| authorships[31].institutions[0].id | https://openalex.org/I4210144945 |
| authorships[31].institutions[0].ror | https://ror.org/04vnqkx80 |
| authorships[31].institutions[0].type | company |
| authorships[31].institutions[0].lineage | https://openalex.org/I4210144945 |
| authorships[31].institutions[0].country_code | JP |
| authorships[31].institutions[0].display_name | Sun Pharma (Japan) |
| authorships[31].author_position | middle |
| authorships[31].raw_author_name | S. Mehta |
| authorships[31].is_corresponding | False |
| authorships[31].raw_affiliation_strings | Sun Pharma |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.cambridge.org/core/services/aop-cambridge-core/content/view/EE6488C9326FA55603972FE2BF7B69B0/S0924933825010867a.pdf/div-class-title-efficacy-and-safety-of-lumateperone-compared-to-quetiapine-in-indian-patients-with-bipolar-ii-depression-a-subgroup-analysis-based-on-age-div.pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Efficacy and Safety of Lumateperone compared to Quetiapine in Indian patients with Bipolar II depression: A subgroup analysis based on age |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10854 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9927999973297119 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2738 |
| primary_topic.subfield.display_name | Psychiatry and Mental health |
| primary_topic.display_name | Bipolar Disorder and Treatment |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1192/j.eurpsy.2025.1086 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S87202501 |
| best_oa_location.source.issn | 0924-9338, 1778-3585 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 0924-9338 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | European Psychiatry |
| best_oa_location.source.host_organization | https://openalex.org/P4310311721 |
| best_oa_location.source.host_organization_name | Cambridge University Press |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310311721, https://openalex.org/P4310311702 |
| best_oa_location.source.host_organization_lineage_names | Cambridge University Press, University of Cambridge |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.cambridge.org/core/services/aop-cambridge-core/content/view/EE6488C9326FA55603972FE2BF7B69B0/S0924933825010867a.pdf/div-class-title-efficacy-and-safety-of-lumateperone-compared-to-quetiapine-in-indian-patients-with-bipolar-ii-depression-a-subgroup-analysis-based-on-age-div.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | European Psychiatry |
| best_oa_location.landing_page_url | https://doi.org/10.1192/j.eurpsy.2025.1086 |
| primary_location.id | doi:10.1192/j.eurpsy.2025.1086 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S87202501 |
| primary_location.source.issn | 0924-9338, 1778-3585 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 0924-9338 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | European Psychiatry |
| primary_location.source.host_organization | https://openalex.org/P4310311721 |
| primary_location.source.host_organization_name | Cambridge University Press |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310311721, https://openalex.org/P4310311702 |
| primary_location.source.host_organization_lineage_names | Cambridge University Press, University of Cambridge |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.cambridge.org/core/services/aop-cambridge-core/content/view/EE6488C9326FA55603972FE2BF7B69B0/S0924933825010867a.pdf/div-class-title-efficacy-and-safety-of-lumateperone-compared-to-quetiapine-in-indian-patients-with-bipolar-ii-depression-a-subgroup-analysis-based-on-age-div.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | European Psychiatry |
| primary_location.landing_page_url | https://doi.org/10.1192/j.eurpsy.2025.1086 |
| publication_date | 2025-04-01 |
| publication_year | 2025 |
| referenced_works_count | 0 |
| abstract_inverted_index.1 | 137 |
| abstract_inverted_index.2 | 143 |
| abstract_inverted_index.3 | 32 |
| abstract_inverted_index.6 | 127 |
| abstract_inverted_index.a | 7, 84 |
| abstract_inverted_index.14 | 274 |
| abstract_inverted_index.1: | 336 |
| abstract_inverted_index.1] | 246 |
| abstract_inverted_index.42 | 233, 277, 298 |
| abstract_inverted_index.A. | 399, 448, 465, 494, 502, 520, 538 |
| abstract_inverted_index.B. | 435 |
| abstract_inverted_index.CI | 251 |
| abstract_inverted_index.D. | 411, 526 |
| abstract_inverted_index.F. | 427 |
| abstract_inverted_index.G. | 431, 457, 461, 473 |
| abstract_inverted_index.II | 53, 78, 354, 394 |
| abstract_inverted_index.K. | 440 |
| abstract_inverted_index.M. | 419, 444, 478 |
| abstract_inverted_index.N. | 490, 498 |
| abstract_inverted_index.P. | 403, 415, 423, 436, 469, 514, 532 |
| abstract_inverted_index.S. | 452, 456, 482, 486, 508, 544 |
| abstract_inverted_index.T. | 474 |
| abstract_inverted_index.Y. | 407 |
| abstract_inverted_index.an | 2, 29 |
| abstract_inverted_index.as | 247, 356, 386 |
| abstract_inverted_index.at | 16 |
| abstract_inverted_index.be | 378, 384 |
| abstract_inverted_index.by | 12 |
| abstract_inverted_index.in | 49, 201, 206, 215, 226, 234, 242, 280, 286, 291, 301, 307, 316, 350, 390 |
| abstract_inverted_index.is | 345 |
| abstract_inverted_index.no | 329 |
| abstract_inverted_index.of | 10, 14, 28, 42, 51, 164, 198, 224, 257, 261, 312, 352, 367, 369, 392, 397 |
| abstract_inverted_index.on | 58, 134 |
| abstract_inverted_index.or | 122 |
| abstract_inverted_index.to | 36, 46, 116, 231, 239, 275, 296, 347, 363, 377 |
| abstract_inverted_index.142 | 205 |
| abstract_inverted_index.320 | 200 |
| abstract_inverted_index.42, | 365 |
| abstract_inverted_index.462 | 195 |
| abstract_inverted_index.95% | 250 |
| abstract_inverted_index.Day | 232, 273, 276, 297, 364 |
| abstract_inverted_index.For | 147 |
| abstract_inverted_index.S2: | 324 |
| abstract_inverted_index.Sun | 506, 512, 518, 524, 530, 536, 542, 548 |
| abstract_inverted_index.The | 63, 100, 111, 129, 209, 221, 259, 289, 310 |
| abstract_inverted_index.age | 59, 368 |
| abstract_inverted_index.and | 20, 40, 92, 107, 141, 157, 162, 167, 175, 204, 267, 283, 304, 322, 326, 328, 372 |
| abstract_inverted_index.arm | 236, 241 |
| abstract_inverted_index.can | 383 |
| abstract_inverted_index.for | 126, 176 |
| abstract_inverted_index.has | 6 |
| abstract_inverted_index.of: | 505, 511, 517, 523, 529, 535, 541, 547 |
| abstract_inverted_index.out | 197 |
| abstract_inverted_index.the | 38, 248, 254, 370 |
| abstract_inverted_index.via | 358 |
| abstract_inverted_index.was | 34, 102, 237, 252 |
| abstract_inverted_index.(D2) | 22 |
| abstract_inverted_index.3.0. | 258 |
| abstract_inverted_index.42mg | 44, 120, 344 |
| abstract_inverted_index.Dey: | 483 |
| abstract_inverted_index.Mane | 539 |
| abstract_inverted_index.None | 401, 405, 409, 413, 417, 421, 425, 429, 433, 438, 442, 446, 450, 454, 459, 463, 467, 471, 476, 480, 484, 488, 492, 496, 500 |
| abstract_inverted_index.Saha | 509 |
| abstract_inverted_index.Test | 235, 282, 303 |
| abstract_inverted_index.This | 25, 191, 338 |
| abstract_inverted_index.[S1: | 320 |
| abstract_inverted_index.age: | 135 |
| abstract_inverted_index.arms | 218, 285, 306, 319 |
| abstract_inverted_index.both | 243, 281, 287, 302, 308, 317, 373 |
| abstract_inverted_index.dual | 8 |
| abstract_inverted_index.form | 169 |
| abstract_inverted_index.from | 229, 272, 294, 361 |
| abstract_inverted_index.life | 165 |
| abstract_inverted_index.that | 342 |
| abstract_inverted_index.well | 379 |
| abstract_inverted_index.were | 113, 131, 173, 184, 213, 278, 299, 314, 333, 375 |
| abstract_inverted_index.when | 55 |
| abstract_inverted_index.with | 76, 80 |
| abstract_inverted_index.(1:1) | 115 |
| abstract_inverted_index.18-45 | 139 |
| abstract_inverted_index.300mg | 48, 124, 349 |
| abstract_inverted_index.Image | 335 |
| abstract_inverted_index.MADRS | 150, 227, 359 |
| abstract_inverted_index.Mehta | 545 |
| abstract_inverted_index.Patil | 527 |
| abstract_inverted_index.Phase | 31 |
| abstract_inverted_index.Shah: | 428 |
| abstract_inverted_index.TEAEs | 313 |
| abstract_inverted_index.[S1]: | 138 |
| abstract_inverted_index.[S2]: | 144 |
| abstract_inverted_index.after | 104 |
| abstract_inverted_index.based | 57, 133 |
| abstract_inverted_index.below | 253 |
| abstract_inverted_index.drug, | 5 |
| abstract_inverted_index.found | 376 |
| abstract_inverted_index.scale | 88 |
| abstract_inverted_index.score | 90, 98, 172, 228, 293, 360 |
| abstract_inverted_index.study | 33, 72, 101 |
| abstract_inverted_index.trial | 187 |
| abstract_inverted_index.upper | 249 |
| abstract_inverted_index.which | 199 |
| abstract_inverted_index.years | 140 |
| abstract_inverted_index.≥20 | 91 |
| abstract_inverted_index.≥4. | 99 |
| abstract_inverted_index.(total | 153, 263 |
| abstract_inverted_index.Dasud: | 416 |
| abstract_inverted_index.Dutta: | 445 |
| abstract_inverted_index.Ghadge | 533 |
| abstract_inverted_index.Goyal: | 458 |
| abstract_inverted_index.Hence, | 381 |
| abstract_inverted_index.Indian | 30, 74 |
| abstract_inverted_index.Kumar: | 495 |
| abstract_inverted_index.Meena: | 424 |
| abstract_inverted_index.Patel: | 408 |
| abstract_inverted_index.Pharma | 549 |
| abstract_inverted_index.Shetty | 503, 521 |
| abstract_inverted_index.Sooch: | 499 |
| abstract_inverted_index.[Test] | 121 |
| abstract_inverted_index.across | 219 |
| abstract_inverted_index.action | 11 |
| abstract_inverted_index.either | 117 |
| abstract_inverted_index.ethics | 108 |
| abstract_inverted_index.events | 182, 332 |
| abstract_inverted_index.global | 94 |
| abstract_inverted_index.having | 83 |
| abstract_inverted_index.margin | 256 |
| abstract_inverted_index.option | 389 |
| abstract_inverted_index.rating | 87 |
| abstract_inverted_index.safety | 41, 177 |
| abstract_inverted_index.score, | 151, 154, 264 |
| abstract_inverted_index.weeks. | 128 |
| abstract_inverted_index.years. | 146 |
| abstract_inverted_index.(18-45, | 60 |
| abstract_inverted_index.(MADRS) | 89 |
| abstract_inverted_index.(TEAEs) | 183 |
| abstract_inverted_index.Bhirud: | 420 |
| abstract_inverted_index.Bipolar | 52, 77, 353, 393 |
| abstract_inverted_index.Devkare | 515 |
| abstract_inverted_index.Harsha: | 475 |
| abstract_inverted_index.Jyothi: | 491 |
| abstract_inverted_index.Methods | 62 |
| abstract_inverted_index.Mistry: | 441 |
| abstract_inverted_index.Parikh: | 479 |
| abstract_inverted_index.Pharma, | 507, 513, 519, 525, 531, 537, 543 |
| abstract_inverted_index.Quality | 163 |
| abstract_inverted_index.Results | 190 |
| abstract_inverted_index.[Figure | 245 |
| abstract_inverted_index.adverse | 181, 331 |
| abstract_inverted_index.between | 216 |
| abstract_inverted_index.bipolar | 159, 269 |
| abstract_inverted_index.central | 17 |
| abstract_inverted_index.illness | 160, 270 |
| abstract_inverted_index.overall | 158, 268 |
| abstract_inverted_index.primary | 222 |
| abstract_inverted_index.receive | 118 |
| abstract_inverted_index.serious | 330 |
| abstract_inverted_index.(5-HT2A) | 19 |
| abstract_inverted_index.CGI-BP-S | 152, 262 |
| abstract_inverted_index.Clinical | 93 |
| abstract_inverted_index.Employee | 504, 510, 516, 522, 528, 534, 540, 546 |
| abstract_inverted_index.Ganesan: | 432 |
| abstract_inverted_index.Interest | 398 |
| abstract_inverted_index.Rathour: | 437 |
| abstract_inverted_index.Sarkhel: | 487 |
| abstract_inverted_index.Subgroup | 136, 142 |
| abstract_inverted_index.activity | 15 |
| abstract_inverted_index.analysis | 27, 193, 340 |
| abstract_inverted_index.assessed | 357 |
| abstract_inverted_index.atypical | 3 |
| abstract_inverted_index.baseline | 210, 230, 295, 362 |
| abstract_inverted_index.compared | 45 |
| abstract_inverted_index.dopamine | 21 |
| abstract_inverted_index.efficacy | 39, 148 |
| abstract_inverted_index.emergent | 180 |
| abstract_inverted_index.endpoint | 223 |
| abstract_inverted_index.evaluate | 37 |
| abstract_inverted_index.included | 73, 194 |
| abstract_inverted_index.moderate | 81 |
| abstract_inverted_index.outcomes | 149, 178 |
| abstract_inverted_index.patients | 75, 112, 130, 371 |
| abstract_inverted_index.severity | 82 |
| abstract_inverted_index.subgroup | 26, 192, 339 |
| abstract_inverted_index.subscore | 156, 266 |
| abstract_inverted_index.valuable | 387 |
| abstract_inverted_index.>45-65 | 145 |
| abstract_inverted_index.Declared, | 402, 406, 410, 414, 418, 422, 426, 430, 434, 439, 443, 447, 451, 455, 460, 464, 468, 472, 477, 481, 485, 489, 493, 497, 501 |
| abstract_inverted_index.Kulkarni: | 462 |
| abstract_inverted_index.Ramaraju: | 449 |
| abstract_inverted_index.[Clinical | 186 |
| abstract_inverted_index.assessed. | 185 |
| abstract_inverted_index.committee | 109 |
| abstract_inverted_index.conducted | 35, 103 |
| abstract_inverted_index.enjoyment | 166 |
| abstract_inverted_index.evaluated | 174 |
| abstract_inverted_index.incidence | 311 |
| abstract_inverted_index.mechanism | 9 |
| abstract_inverted_index.patients, | 196 |
| abstract_inverted_index.receiving | 105 |
| abstract_inverted_index.reduction | 225, 260 |
| abstract_inverted_index.reported. | 334 |
| abstract_inverted_index.serotonin | 18 |
| abstract_inverted_index.subgroups | 244 |
| abstract_inverted_index.subscore) | 271 |
| abstract_inverted_index.treatment | 50, 179, 217, 318, 351, 388 |
| abstract_inverted_index.(CGI-BP-S) | 97 |
| abstract_inverted_index.Chaudhary: | 470 |
| abstract_inverted_index.Chaurasia: | 404 |
| abstract_inverted_index.Choudhary: | 412 |
| abstract_inverted_index.Comparator | 240, 284, 305 |
| abstract_inverted_index.Disclosure | 396 |
| abstract_inverted_index.Objectives | 24 |
| abstract_inverted_index.Q-LES-Q-SF | 292 |
| abstract_inverted_index.Quetiapine | 47, 123, 348 |
| abstract_inverted_index.Test=31.4% | 321 |
| abstract_inverted_index.Test=41.7% | 325 |
| abstract_inverted_index.approvals. | 110 |
| abstract_inverted_index.comparable | 214, 279, 300, 315 |
| abstract_inverted_index.considered | 385 |
| abstract_inverted_index.depression | 54, 79, 86, 155, 265, 355 |
| abstract_inverted_index.management | 391 |
| abstract_inverted_index.phase-III, | 64 |
| abstract_inverted_index.randomized | 114 |
| abstract_inverted_index.receptors. | 23 |
| abstract_inverted_index.regulatory | 106 |
| abstract_inverted_index.stratified | 56, 132 |
| abstract_inverted_index.subgroups. | 220, 288, 309 |
| abstract_inverted_index.subscore), | 161 |
| abstract_inverted_index.tolerated. | 380 |
| abstract_inverted_index.treatments | 374 |
| abstract_inverted_index.>45-65). | 61 |
| abstract_inverted_index.Conclusions | 337 |
| abstract_inverted_index.S2[Test=72; | 207 |
| abstract_inverted_index.combination | 13 |
| abstract_inverted_index.demographic | 211 |
| abstract_inverted_index.depression. | 395 |
| abstract_inverted_index.improvement | 290 |
| abstract_inverted_index.pre-defined | 255 |
| abstract_inverted_index.randomized, | 65 |
| abstract_inverted_index.(Q-LES-Q-SF) | 171 |
| abstract_inverted_index.Introduction | 0 |
| abstract_inverted_index.Lumateperone | 43, 119, 343, 382 |
| abstract_inverted_index.Mangalwedhe: | 453 |
| abstract_inverted_index.S1[Test=159; | 202 |
| abstract_inverted_index.[Comparator] | 125 |
| abstract_inverted_index.comparative, | 70 |
| abstract_inverted_index.demonstrated | 341 |
| abstract_inverted_index.irrespective | 366 |
| abstract_inverted_index.non-inferior | 238, 346 |
| abstract_inverted_index.Lumateperone, | 1 |
| abstract_inverted_index.Mukhopadhyay: | 466 |
| abstract_inverted_index.antipsychotic | 4 |
| abstract_inverted_index.questionnaire | 170 |
| abstract_inverted_index.registration: | 188 |
| abstract_inverted_index.Dharmadhikari: | 400 |
| abstract_inverted_index.multi-centric, | 66 |
| abstract_inverted_index.Comparator=161] | 203 |
| abstract_inverted_index.Comparator=70]. | 208 |
| abstract_inverted_index.assessor-blind, | 67 |
| abstract_inverted_index.characteristics | 212 |
| abstract_inverted_index.non-inferiority | 71 |
| abstract_inverted_index.parallel-group, | 68 |
| abstract_inverted_index.Comparator=32.9%] | 327 |
| abstract_inverted_index.Comparator=36.6%; | 323 |
| abstract_inverted_index.Montgomery-Asberg | 85 |
| abstract_inverted_index.active-controlled, | 69 |
| abstract_inverted_index.satisfaction-short | 168 |
| abstract_inverted_index.version–severity | 96 |
| abstract_inverted_index.CTRI/2023/10/058583] | 189 |
| abstract_inverted_index.impression–bipolar | 95 |
| cited_by_percentile_year | |
| countries_distinct_count | 2 |
| institutions_distinct_count | 32 |
| citation_normalized_percentile.value | 0.50442916 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |